Stocks to Watch: Tata Motors, SBI, Adani Wilmar, PB Fintech, IndiGo, Lupin, and Others

Stocks To Watch October 6: GIFT Nifty on the NSE IX traded 8.5 points, or 0.04 per cent, higher at 19,613.5, signaling that Dalal Street was headed for muted start on Friday. Here’s a slew of stocks that will be in focus today for various reasons.

Tata Motors: Tata Motors arm JLR said it expects positive free cash flow of around £300 million in the second quarter of FY24. It reported increased sales volumes in Q2, reflecting continuing improvement in supply, allowing JLR to deliver more vehicles to clients.

SBI: The union government has extended SBI Chairman Dinesh Khara’s tenure till August 2024.

Rate sensitives: Shares of rate sensitives such as banks, financial services companies, automobile, and real estate firm will see action today amid the Reserve Bank of India’s (RBI) interest rate decision.

Valiant Laboratories: Valiant Laboratories will debut on the bourses on October 6. The issue price is Rs. 140 per share.

Bajaj Finance: The Board has approved to raise Rs 10,000 crore through a combination of QIP and preferential issue.

PB Fintech: SoftBank Group is likely to sell shares worth up to $105 million in PB Fintech via block deals, reports said.

The Group is looking to divest around 2.54 per cent stake at Rs 752 – 767 per share.

Vedanta: CRISIL Ratings on Thursday placed the long-term bank facilities and debt instruments of Vedanta Limited under ‘rating watch with negative implications’.

InterGlobe Aviation: IndiGo airlines will charge fuel charge between Rs 300 and Rs 1000 to offset the impact of rising Aviation turbine fuel (ATF). The new pricing structure will come into effect from October 6.

Godrej Consumer Products: The company estimated double-digit growth in organic sales in the September quarter despite facing challenges in a tough macroeconomic environment. Consolidated sales could be in low single digit.

Adani Wilmar: Edible oil volumes grew 5 per cent year-on-year, while Food and FMCG volumes grew 18 per cent YoY in Q2-FY24. However, standalone sales value growth fell 13 per cent YoY due to the price cuts taken on account of the sharp fall in global edible oil prices.

Sun Pharma: The company has decided to acquire a 37.76 per cent stake in Ezerx Health Tech Private Limited.

Lupin: The company has received tentative approval from the United States Food and Drug Administration (US FDA) for Tolvaptan Tablets, 15 mg, 30 mg, 45 mg, 60 mg, and 90 mg.

Disclaimer:Disclaimer: The views and investment tips by experts in this News18.com report are their own and not those of the website or its management. Users are advised to check with certified experts before taking any investment decisions.